ASP IsotopesASPI
ASPI
About: ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
Employees: 76
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
289% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 9
135% more capital invested
Capital invested by funds: $62.4M [Q3] → $147M (+$84.3M) [Q4]
100% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 17
37% more funds holding
Funds holding: 68 [Q3] → 93 (+25) [Q4]
11.79% more ownership
Funds ownership: 33.6% [Q3] → 45.38% (+11.79%) [Q4]
31% less call options, than puts
Call options by funds: $2.61M | Put options by funds: $3.81M
Research analyst outlook
We haven’t received any recent analyst ratings for ASPI.
Financial journalist opinion
Based on 16 articles about ASPI published over the past 30 days
Neutral
Accesswire
5 hours ago
ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Neutral
GlobeNewsWire
7 hours ago
ASP Isotopes Inc. Completes Commissioning of First Quantum Enrichment Laser System and Starts Production of Commercial Samples of Ytterbium-176
- Ytterbium-176 is a critical material used in the production of radioisotopes for oncology treatments, including Novartis' Pluvicto.
Neutral
GlobeNewsWire
1 day ago
ASP Isotopes Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results Webinar
WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), announced that it will release its fourth quarter and fiscal year 2024 financial results after the close of financial markets today, March 31, 2025, with a webinar to follow tomorrow, Tuesday, April 1, 2025 at 10:00 am ET, 3:00 pm UK time, 4:00 pm South African time.
Neutral
Accesswire
2 days ago
ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Neutral
Accesswire
5 days ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / March 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Neutral
Accesswire
1 week ago
Bronstein, Gewirtz & Grossman, LLC Encourages ASP Isotopes Inc. (ASPI) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Neutral
Accesswire
1 week ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ASP Isotopes Inc. (ASPI) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Neutral
Accesswire
1 week ago
ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Neutral
Accesswire
2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ASP Isotopes Inc. (ASPI) And Encourages Stockholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / March 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Neutral
Accesswire
2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / March 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Charts implemented using Lightweight Charts™